Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Sales | 1,081,700 | 876,500 | 952,700 | 882,400 | 875,300 |
| Cost of Goods | 613,400 | 455,600 | 511,200 | 484,600 | 498,000 |
| Gross Profit | 468,300 | 420,900 | 441,500 | 397,800 | 377,300 |
| Operating Expenses | 350,400 | 310,700 | 386,700 | 364,000 | 261,600 |
| Operating Income | 118,300 | 110,800 | 55,000 | 34,400 | 115,700 |
| Interest Expense | 22,900 | 21,800 | 22,400 | 21,400 | 20,000 |
| Other Income | 200 | -2,900 | -500 | 500 | 2,800 |
| Pre-tax Income | 95,600 | 86,100 | 32,100 | 13,500 | 98,500 |
| Income Tax | 43,200 | 41,300 | 14,900 | -12,200 | 27,900 |
| Net Income Continuous | 52,400 | 44,800 | 17,200 | 25,700 | 70,600 |
| Minority Interests | -300 | -500 | N/A | 0 | 0 |
| Net Income | $52,700 | $45,300 | $18,300 | $25,700 | $70,600 |
| EPS Basic Total Ops | 0.42 | 0.37 | 0.15 | 0.21 | 0.58 |
| EPS Basic Continuous Ops | 0.42 | 0.36 | 0.14 | 0.21 | 0.58 |
| EPS Diluted Total Ops | 0.42 | 0.36 | 0.13 | 0.21 | 0.57 |
| EPS Diluted Continuous Ops | 0.41 | 0.36 | 0.13 | 0.21 | 0.57 |
| EBITDA(a) | $218,600 | $190,400 | $132,500 | $105,400 | $185,400 |